top of page

GLOBAL DEAL SYNDICATION

HBS Alumni Angels syndicates selected deals across the full global membership of its 14 chapters. This enables selected deals from one chapter to reach a global network of accredited investor alumni. This is a unique benefit of being a member in a local HBS Alumni Angel chapter. Investment decisions are made and executed individually following a global webinar. Once investments are made, investors often assist companies in other areas as formal or informal advisers.

For details on how the process works, please scroll down.

HOW IT WORKS

Use arrows on the side to navigate

1. HOST CHAPTER

A company must meet a threshold of member investment in one of our HBS Alumni Angel Chapters listed here. The leadership of the host chapter nominates the company for global syndication and provides a local member contact to act as syndication lead and a company contact.

CRITERIA

Ideally, for global syndication, a company should meet the following requirements:

  • Local host chapter members committed to invest at least $50,000* and local chapter forwards deal to global for syndication; 

  • Company assures at least $50,000-100,000 investible capacity;

  • Company provides at least 2 weeks for due diligence following the webinar, prior to requiring an investment decision;

  • Minimum individual investment amount is set at $25,000 or less;

  • Company agrees to a one-time admin fee of $1500.


The Global Syndication Committee selects the most suitable company candidates from the 15 participating HBSAA chapters and is aiming to host monthly webinars. 

​

*NY and other larger chapters may have a $100,000 min.

UPCOMING SYNDICATION CALLS

20260604 AMI-header-logo.png

GLOBAL SYNDICATED INVESTMENT PRESENTATION:
ACTUATED MEDICAL - NEURALGLIDER

Thursday, June 4, 2026 9am PT, 12pm ET, 5pm London, 6pm Continental Europe

Presenter:
President & CEO, Maureen Mulvihill
For HBS Angels Members ONLY

 

On behalf of the Boston chapter, we would like to share the following investment opportunity:
 

Actuated Medical

Transformative Tools for Brain Access & Deep Brain Therapy Delivery To Treat Debilitating Neurological Conditions

​

Company Summary: Actuated Medical

Since 2006, Actuated Medical has been dedicated to improving patient outcomes by integrating motion into medical devices. Developed with $18M in non-dilutive funding, our NeuralGlider® technology uses gentle oscillation for less invasive brain implant insertion and targeted drug delivery. We’re tapping into multi-billion-dollar neurological disease treatment markets – including treatment-resistant addiction, depression and Parkinson’s Disease. Our NeuralGlider Inserter inserts brain implants with greater precision and less tissue damage to improve implant performance and longevity. The NeuralGlider Injector enables targeted drug delivery deep into the brain with finer, less invasive needles to minimize tissue trauma and medication loss – including brain cancer treatment, AAV-gene therapy infusion, and addiction treatments. 44+ third-party publications citing NeuralGlider are strengthening the scientific foundation to transition to clinical indications. Our first clinical goal is to improve deep brain stimulation (DBS) probe insertion, reducing clinician variability and the need for revision surgeries, demonstrated initially in Parkinson’s patients.

​

First Market, Proving Ground

10M+ People globally have treatment resistant neurological conditions, such as Parkinson’s Disease, epilepsy, obsessive-compulsive disorder (OCD), and depression that are candidates for DBS treatments.
DBS can give them their lives back, when other treatments fail.

Complex tissue dynamics result from the many different tissue layers in the brain that the probe transverses. Therefore, as DBS probes are inserted, 3-8% of the time the probe tip misses the target (~1 in 20 patients), or shifts after the tip is put in place, leading to off target effects, sub-optimal treatment, or potentially a costly second brain surgery.

 

Solution

NeuralGlider uses patented gentle oscillating technology and a coupling mechanism to insert brain implants precisely with less force and damage to tissue. Preclinical studies have shown the ability to hit small targets in the brain more accurately, resulting in improved implant performance and outcomes.

​

Actuated Medical’s $10M Series A will accelerate its global leadership in brain access and deep‑brain therapy delivery. The company has a clear 5‑year exit plan focused on achieving FDA 510(k) regulatory clearance, key clinical milestones, and licensing events that position the company for acquisition by a neural strategic within 5–6 years. The financing strategy is designed to minimize dilution: revenue from profitable NeuralGlider research sales plus the planned divestiture of two non‑core FDA‑cleared assets will be reinvested to fund growth and reduce the need for future rounds. Backed by 45 issued U.S. and international patents, 9 FDA 510(k) clearances, and eight clinical studies, Actuated has the IP, regulatory track record, and clinical experience to execute the plan and drive value for their investor.

 

NeuralGlider Traction:

  • Several human studies that will use NeuralGlider as the brain access device are planned for 2026–2027 | Researchers at Harvard/MGH have pending study using NeuralGlider to insert next generation probes into human excised tissue, and then human patients to study brain function

  • UMass Pediatric Neurosurgeon enthusiastic about improving targeting of AAV-Gene Therapy Infusion and insertion of SEEG probes for epilepsy mapping.

  • Strong engagement using NeuralGlider to deliver therapeutics directly to glioblastoma, a brain cancer with ~13,000 US diagnoses annually and a 5–10% survival rate.  

  • Three next-generation brain computer interface (BCI) groups are actively engaging and moving forward with (research) NeuralGlider purchases to improve BCI insertion.

  • The single-use clinical NeuralGlider tool is anticipated as an FDA 510(k) clearance.

 

Series A highlights:

  • $10M Series A | $25M pre-money

  • Minimum check $25k

  • First $1.5M Tranche | Eligible for 30% warrants @50% discount | Reduces pre-money to $22.1M

  • Unique funding plan | Planned sell-off two FDA cleared medical device in next 24 Months | Profits reinvested to fuel growth | Minimizes future shareholder dilution | Distributions Planned

  • QSBA entity structure

  • Status | $700k invested to date | $1.2M committed

  • Potential SBIR investment matching | Reauthorized program includes a Strategic Breakthrough program | Pending release of eligibility requirements by NIH

  • Keiretsu Forum - Mid Atlantic Term Sheet and Due Diligence Report available

​

Team
Maureen Mulvihill, PhD, President & CEO
Roger Bagwell, PhD, Director, Neural Device Operations

Douglas Dillon, MS, Director, QA & RA
Ian Charney, Director, Manufacturing

Christian Haller, Advisor​​

More Info

Solution

20260604 Solution NeuralGlider.png

Market Size

NeuralGlider Platform has Growing Opportunities

$10M Series A Use of Proceeds

Physicians and Clinical Feedback

Projected Timeline to Investor Return

Financials

MAUREEN MULVIHILL

PRESIDENT & CEO

20260604 Maureen_Mulvihill_Actuated_Medic.jpg

Maureen L. Mulvihill, Ph.D., 2020 Life Sciences Pennsylvania CEO of the Year, is President & CEO of Actuated Medical, a Central Pennsylvania medical device innovator. She leads a team developing transformative tools to improve insertion of brain probes — including deep brain stimulation, brain‑computer interfaces, and next‑generation implants — and to advance delivery of deep‑brain therapies such as cancer biologics, gene therapy, and treatments for addiction. Under her leadership, Actuated has secured $50M in non‑dilutive funding (primarily SBIR), 45 patents, nine FDA 510(k) clearances, and two SBA Tibbetts Awards for SBIR excellence. Maureen serves on the AdvaMed Board of Directors, the AdvaMed Accel Board, and the Life Sciences PA Board, representing small MedTech manufacturers. She chairs the Industrial Advisory Board for the Penn State Center for Biodevices and is a member of the Kish Bank Regional Advisory Board. She has received more than 35 entrepreneurial awards, including serving as a U.S. delegate to the 2017 Global Entrepreneurship Summit in India, is an alumna of the Goldman Sachs 10,000 Small Businesses program, and earned her Ph.D. from Penn State.

The Zoom Meeting information will be in your registration confirmation email.
Please check your junk/spam/bulk folders if you don't see it.

PREVIOUS SYNDICATION CALLS

20260423 BOUNCE-Logo.png

GLOBAL SYNDICATED INVESTMENT PRESENTATION:
BOUNCE IMAGING

Thursday, April 23, 2026 9am PT, 12pm ET, 5pm London, 6pm Continental Europe

Presenter:
CEO & Founder, Francisco Aguilar
For HBS Angels Members ONLY

 

On behalf of the New York chapter, we would like to share the following investment opportunity:
 

Bounce Imaging

Bounce Imaging develops deployable 360° sensing systems that give military, public safety, and inspection teams real-time visibility inside dangerous, confined, or denied environments.

 

The In-Q-Tel-backed company has reached profitability and scale by combining patented imaging technology with deep systems and user integration to deliver a scalable, high-margin platform already in active use across U.S. and allied government markets.

​

Company Summary: Bounce Imaging

​

Summary

Bounce Imaging develops ruggedized, deployable sensor systems that provide real-time situational awareness in dangerous, confined, or denied environments. The company serves defense, public safety, and inspection markets with a differentiated platform combining hardware, software, and communications integration.

 

The company is already profitable and growing, with strong gross margins (60–75%) and expanding international demand.
Its systems are deployed broadly across U.S. and allied government users, and the company is positioned to scale into multi-billion-dollar global markets.

​

Problem Being Solved

Operational teams (military, law enforcement, and rescue personnel) are routinely required to enter unknown, high-risk environments without adequate visibility.

 

Existing solutions—primarily robots and drones—have structural limitations in these scenarios:

  • Ineffective in confined or obstructed spaces

  • Limited endurance (battery constraints)

  • Operational complexity under stress

  • Poor portability and deployment speed

 

This creates a persistent gap in rapid, low-risk situational awareness at the point of entry.

 

Solution

Bounce Imaging provides deployable, panoramic sensing systems that can be rapidly inserted into environments to deliver immediate 360° visibility.

 

Key characteristics:

  • Instant deployment (throwable, pole-mounted, lowered, or integrated with platforms)

  • Real-time 360° video and sensor data

  • Operable across multiple mission profiles (tactical, inspection, rescue)

 

Core technical advantages:

  • Highly efficient panoramic stitching enabling long battery life and low latency

  • Stabilization and orientation capabilities even during motion

  • Compatibility with thermal and non-visual sensing modalities

  • Intuitive first-person software interface

 

The platform also extends into:

  • Edge AI integration (orientation-aware detection)

  • Integration with existing vehicles, robots, and comms systems

  • Multi-spectral and next-generation sensor products

 

Traction

Bounce Imaging demonstrates strong commercial and operational validation:

 

Financial performance:

  • ~$1.9M (2023) → ~$10.1M (2025 actual) → projected ~$31.7M (2026)

  • Gross margins: ~60–75%

  • Transitioned to profitability (positive EBITDA as of 2024)

 

Customer adoption (generalized for compliance):

  • Widely deployed across the most elite U.S. federal, state, and local agencies

  • Used by multiple international allied defense organizations

  • Hundreds of agency-level deployments globally

 

Programmatic traction:

  • Participation in major government programs and contract vehicles

  • Multi-year procurement pathways in place

  • Increasing alignment with international defense budgets (e.g., NATO-aligned spending growth)

 

Market tailwinds:

  • Significant increases in U.S. and allied defense spending

  • Expanding demand for ISR, robotics, and situational awareness systems

 

IP and Barriers to Entry

Bounce Imaging has built defensible technical and integration moats:

 

Intellectual Property:

  • 13 issued U.S. patents covering:

    • Panoramic imaging efficiency

    • Stabilization and synchronization

    • Orientation and coordinate systems

    • Sensor fusion and interface design

  • Extensive trade secrets in hardware and software implementation

 

System-level barriers:

  • Deep integration with tactical communications ecosystems (mesh radios, mobile platforms, and software environments)

  • Compatibility with widely used operational software frameworks (e.g., tactical situational awareness tools)

  • Multi-year integration investment required to replicate ecosystem position

 

Team

The company combines deep domain expertise across engineering, defense, and commercialization:

  • Founder/CEO: Background in strategy, telecom, and international markets

  • COO/Defense Lead: Former military aviation officer with operational leadership experience

  • CTO and engineering leadership: Decades of experience in computer vision, embedded systems, and imaging hardware

  • CGO/Growth leadership: Experience in government, venture capital, and scaling organizations

 

Board and advisors include:

  • Senior defense policy leadership

  • AI and technology pioneers with prior successful exits

 

Deal Terms

  • Instrument: Convertible note

  • Valuation cap: $50M

  • Discount: 20%

  • Target raise: ~$3M

  • ~75% already committed by existing investors and insiders

 

Use of funds:

  • Scaling production capacity

  • Expanding sales and marketing

  • Advancing next-generation R&D

​

FRANCISCO AGUILAR

CEO & FOUNDER

20260423 Aguilar 600X.png

Francisco Aguilar is the Founder and CEO of Bounce Imaging, a dual-use robotics and imaging company serving defense, public safety, and industrial markets. He has led the company from its origins at MIT and Harvard to a patented, globally deployed platform for situational awareness, with products recognized as Best Inventions by TIME/CNN/Popular Science/Verizon and other leading outlets and adopted across U.S. and allied government markets. Prior to Bounce, his experience spans strategy and finance across advanced materials, telecommunications, the social sector, and energy markets. Aguilar holds an MBA from MIT Sloan, an MPP from Harvard Kennedy School, and an A.B. from Harvard.

PAST SYNDICATED COMPANIES

20260423 BOUNCE-Logo
20251212 Waku logo
20250805 Spaceflight logo
20250724 Thermology Health logo_edited
20250805 Spaceflight logo
20250710 Stratagen logo
20250605 moxie scrubs - moxie360 2
20250410 Osteoboost
20250116 Soteri Skin logo
20241121 VonVascular_Logo_Color
20241117 SUNRAYscientific-NewLogo
20240919 pathotrak
20240905 SYND CO2_Split 1280 × 720
20210614 MomiBaby logo cropped
20221117 Agile Devices HIRES_edited
20240229 WURQ Logo1
20240201 Nuvio Mobility
20231219 pente_logo
20221011 Moxie_Scrubs_Logo NEW_edited
20230727 Mercator logo
20230715 Fuego logo
20230323 Measure Studio logo hi-res 300X90
20230126 Avadain Logo tm
20210614 MomiBaby logo cropped
20221201 EarthGrid_COLOR 200X50
20221117 Agile Devices HIRES_edited
20221110 Epilogue Systems logo
20221011 Moxie_Scrubs_Logo NEW_edited
20220922 TANG app 400X210
20220908 Beckon-FullLogo 400X252
20220531 SurgiBox logo 200X133
20220523 Alleviate-Therapy 200X
20220425 egs-logo
20220413 Eunimart logo 300X
20220201 Lingrove
20210906 Moxie_Scrubs_Logo 500X135
20210819 Landsdowne Labs
20210722 RocketStar
20210614 MomiBaby logo cropped
20210527 Cognoptix logo 200X36
20210427 Synd Call LUPII_LOGO 200X
20210121 TANG app 2 150X
20201209 Wave logo 200X
20201203 Beckon logo
20201119%20Syndication%20Dover%20Microsy
20200826 New View logo
20200813%2520COLORONLY%2520logo_edited_e
20200811 BrightSpec Logo
unnamed
Wheeli
Vaporox
Cargo Chief
MyndBlue
Health Hero
agencyQ
HIPAAtrek
IrriGreen
SIA
Tire Agent
Wibmo

HBS Alumni Angels Association
© Copyright HBS Alumni Angels Association
ALL RIGHTS RESERVED.

  • Instagram
  • Facebook - Black Circle
  • Twitter - Black Circle
  • LinkedIn - Black Circle
bottom of page